Free Trial

60,348 Shares in Centene Co. (NYSE:CNC) Acquired by Voleon Capital Management LP

Centene logo with Medical background

Voleon Capital Management LP acquired a new stake in Centene Co. (NYSE:CNC - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 60,348 shares of the company's stock, valued at approximately $3,656,000.

Other institutional investors have also made changes to their positions in the company. Capital Advisors Ltd. LLC boosted its stake in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after buying an additional 177 shares during the last quarter. Hurley Capital LLC bought a new position in Centene in the fourth quarter valued at approximately $26,000. Rialto Wealth Management LLC acquired a new stake in shares of Centene in the 4th quarter valued at approximately $30,000. OFI Invest Asset Management bought a new stake in Centene during the fourth quarter worth $33,000. Finally, SRS Capital Advisors Inc. grew its position in shares of Centene by 73.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock valued at $38,000 after acquiring an additional 267 shares during the period. Institutional investors own 93.63% of the company's stock.

Centene Price Performance

NYSE:CNC traded up $0.69 during trading hours on Friday, hitting $60.10. The company's stock had a trading volume of 5,390,493 shares, compared to its average volume of 4,765,245. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The company has a market capitalization of $29.90 billion, a P/E ratio of 9.63, a PEG ratio of 0.80 and a beta of 0.53. Centene Co. has a twelve month low of $55.03 and a twelve month high of $80.59. The stock has a fifty day simple moving average of $60.17 and a 200-day simple moving average of $60.56.

Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. The business had revenue of $46.62 billion during the quarter, compared to analysts' expectations of $43.16 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The firm's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.26 EPS. On average, analysts anticipate that Centene Co. will post 6.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Barclays reduced their price target on Centene from $93.00 to $84.00 and set an "overweight" rating for the company in a report on Monday, April 28th. Robert W. Baird dropped their price target on Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Wells Fargo & Company decreased their price objective on shares of Centene from $76.00 to $72.00 and set an "overweight" rating on the stock in a report on Friday, February 14th. Jefferies Financial Group decreased their price target on shares of Centene from $64.00 to $61.00 and set a "hold" rating on the stock in a research note on Tuesday. Finally, Argus cut Centene from a "buy" rating to a "hold" rating in a report on Thursday, February 6th. Seven analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $79.77.

Read Our Latest Analysis on Centene

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Recommended Stories

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines